AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.24%165.220.7%$1347.13m
LLYEli Lilly & Co. 1.47%326.291.1%$1083.43m
ABBVAbbVie, Inc. 1.65%140.601.9%$866.31m
PFEPfizer Inc. 1.34%44.730.9%$808.83m
BMYBristol-Myers Squibb Co. 1.28%71.431.0%$782.53m
MRKMerck & Co., Inc. 1.03%88.450.7%$717.67m
AZNAstraZeneca Plc 2.18%56.761.0%$395.93m
ALNYAlnylam Pharmaceuticals, Inc. 1.33%199.418.2%$220.28m
GSKGSK Plc 2.15%30.900.3%$214.16m
NVSNovartis AG 1.79%78.040.2%$205.26m
GBTGlobal Blood Therapeutics, Inc. -0.01%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 3.69%349.113.9%$191.09m
HZNPHorizon Therapeutics Plc 2.86%66.105.4%$178.62m
ATXIAvenue Therapeutics, Inc. 26.50%14.560.0%$176.22m
SRPTSarepta Therapeutics, Inc. 1.72%111.8312.4%$139.09m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.